Biomarkers for predicting the outcome of various cancer immunotherapies
Author:
Funder
Iran's National Elites Foundation
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference234 articles.
1. Natural and induced T regulatory cells in cancer;Adeegbe;Front. Immunol.,2013
2. The potential of radiomic-based phenotyping in precision medicine: A. Review;Aerts;JAMA Oncol.,2016
3. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach;Aerts;Nat. Commun.,2014
4. Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti‐CD52 antibodies;Albitar;Cancer,2004
5. Circulating tumor cells: liquid biopsy of cancer;Alix-Panabieres;Clin. Chem.,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cell death pathways: molecular mechanisms and therapeutic targets for cancer;MedComm;2024-09
2. Insights into the prognostic value and immunological role of CD74 in pan-cancer;Discover Oncology;2024-06-11
3. Implementation of Modern Therapeutic Drug Monitoring and Lipidomics Approaches in Clinical Practice: A Case Study with Colistin Treatment;Pharmaceuticals;2024-06-07
4. Vaccines in Breast Cancer: Challenges and Breakthroughs;Diagnostics;2023-06-26
5. Biomarkers for Cancer: A Detail Review;French-Ukrainian Journal of Chemistry;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3